29.80
-0.35
(-1.16%)
At close: 1:30:20 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
39,758.00
76,219.00
132,673.00
92,875.00
105,300.00
Investing Cash Flow
20,496.00
36,791.00
-13,675.00
960.00
-1,125.00
Financing Cash Flow
-49,082.00
-55,620.00
-61,400.00
-43,803.00
-14,174.00
End Cash Position
446,243.00
423,515.00
367,065.00
306,721.00
257,763.00
Capital Expenditure
-11,928.00
-28,886.00
-6,630.00
-834.00
-7,736.00
Free Cash Flow
27,830.00
47,333.00
126,043.00
92,041.00
97,564.00
12/31/2020 - 12/28/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
3176.TWO Medigen Biotechnology Corp.
32.60
-1.21%
4142.TW Adimmune Corporation
22.60
-1.74%
1762.TW Chunghwa Chemical Synthesis & Biotech Co., Ltd.
33.20
+0.30%
1760.TW Panion & Bf Biotech Inc.
82.70
+1.10%
4130.TWO Genovate Biotechnology Co., Ltd.
25.30
+1.81%
3205.TWO Sagittarius Life Science Corp
33.95
-1.59%
4167.TWO Savior Lifetec Corporation
19.75
-0.25%
1734.TW Sinphar Pharmaceutical Co.,Ltd.
30.75
+0.33%
6492.TWO Senhwa Biosciences, Inc.
42.35
+0.47%
4147.TWO TaiMed Biologics Inc.
86.50
+0.35%